Ducommun Serge, Deak Maria, Sumpton David, Ford Rebecca J, Núñez Galindo Antonio, Kussmann Martin, Viollet Benoit, Steinberg Gregory R, Foretz Marc, Dayon Loïc, Morrice Nicholas A, Sakamoto Kei
Nestlé Institute of Health Sciences SA, EPFL Innovation Park, bâtiment G/H, 1015 Lausanne, Switzerland; School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland.
Nestlé Institute of Health Sciences SA, EPFL Innovation Park, bâtiment G/H, 1015 Lausanne, Switzerland.
Cell Signal. 2015 May;27(5):978-88. doi: 10.1016/j.cellsig.2015.02.008. Epub 2015 Feb 13.
AMP-activated protein kinase (AMPK) is a key cellular energy sensor and regulator of metabolic homeostasis. Although it is best known for its effects on carbohydrate and lipid metabolism, AMPK is implicated in diverse cellular processes, including mitochondrial biogenesis, autophagy, and cell growth and proliferation. To further our understanding of energy homeostasis through AMPK-dependent processes, the design and application of approaches to identify and characterise novel AMPK substrates are invaluable. Here, we report an affinity proteomicstrategy for the discovery and validation of AMPK targets using an antibody to isolate proteins containing the phospho-AMPK substrate recognition motif from hepatocytes that had been treated with pharmacological AMPK activators. We identified 57 proteins that were uniquely enriched in the activator-treated hepatocytes, but were absent in hepatocytes lacking AMPK. We focused on two candidates, cingulin and mitochondrial fission factor (MFF), and further characterised/validated them as AMPK-dependent targets by immunoblotting with phosphorylation site-specific antibodies. A small-molecule AMPK activator caused transient phosphorylation of endogenous cingulin at S137 in intestinal Caco2 cells. Multiple splice-variants of MFF appear to express in hepatocytes and we identified a common AMPK-dependent phospho-site (S129) in all the 3 predominant variants spanning the mass range and a short variant-specific site (S146). Collectively, our proteomic-based approach using a phospho-AMPK substrate antibody in combination with genetic models and selective AMPK activators will provide a powerful and reliable platform for identifying novel AMPK-dependent cellular targets.
AMP激活的蛋白激酶(AMPK)是细胞能量的关键传感器和代谢稳态的调节因子。尽管它以对碳水化合物和脂质代谢的影响而最为人所知,但AMPK参与多种细胞过程,包括线粒体生物发生、自噬以及细胞生长和增殖。为了通过AMPK依赖的过程进一步了解能量稳态,设计和应用识别及表征新型AMPK底物的方法具有重要价值。在此,我们报告了一种亲和蛋白质组学策略,用于发现和验证AMPK靶点。该策略使用一种抗体从经药理学AMPK激活剂处理的肝细胞中分离含有磷酸化AMPK底物识别基序的蛋白质。我们鉴定出57种蛋白质,它们在激活剂处理的肝细胞中特异性富集,但在缺乏AMPK的肝细胞中不存在。我们聚焦于两个候选蛋白,cingulin和线粒体分裂因子(MFF),并通过用磷酸化位点特异性抗体进行免疫印迹进一步将它们表征/验证为AMPK依赖的靶点。一种小分子AMPK激活剂导致肠Caco2细胞中内源性cingulin在S137处瞬时磷酸化。MFF的多个剪接变体似乎在肝细胞中表达,我们在跨越质量范围的所有3种主要变体以及一个短的变体特异性位点(S146)中鉴定出一个共同的AMPK依赖磷酸化位点(S129)。总体而言,我们基于蛋白质组学的方法,即使用磷酸化AMPK底物抗体结合遗传模型和选择性AMPK激活剂,将为鉴定新型AMPK依赖的细胞靶点提供一个强大而可靠的平台。